REQUEST A DEMO
Total
USD $0.00
Search more companies

Ruby Biopharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ruby Biopharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ruby Biopharma Private Limited is an enterprise located in India, with the main office in Mumbai. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on January 21, 2008. There was a net sales revenue increase of 23.18% reported in Ruby Biopharma Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a growth of 52.49%. In 2025, Ruby Biopharma Private Limited’s net profit margin decreased by 1.37%.

Legal Address
11A Sandeep Park Deonar
Mumbai; Maharashtra; Postal Code: 400088

Contact Details: Purchase the Ruby Biopharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ruby Biopharma Private Limited report to view the information.
Financial Auditors:
Purchase the Ruby Biopharma Private Limited report to view the information.
Incorporation Date:
January 21, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Ruby Biopharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
23.18%
Total Operating Revenue
24.25%
Operating Profit
6.19%
EBITDA
3.23%
Net Profit/Loss for the Period
11.03%
Total Assets
52.49%
Total Equity
22.98%
Operating Profit Margin
-2.58%
Net Profit Margin
-1.37%
Return on Equity (ROE)
-2.01%
Debt / Equity
45.67%
Quick Ratio
-0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?